Is ADXS or EQR a better dividend investment in 2026?

ADXS currently yields 331.37% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: ADXS offers higher current income.

What is the dividend yield difference between ADXS and EQR?

ADXS has a forward dividend yield of 331.37% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 325.50 percentage points.

Home › Compare › ADXS vs EQR

ADXS vs EQR: Dividend Comparison 2026

ADXS yields 331.37% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADXS wins by $2987.26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADXS

● Live price

331.37%

Share price

$0.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2987.30M

Annual income

$1,874,518,858.21

Full ADXS calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — ADXS vs EQR

📍 ADXS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADXS	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADXS + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADXS pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXS

Annual income on $10K today (after 15% tax)

$28,166.68/yr

After 10yr DRIP, annual income (after tax)

$1,593,341,029.48/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, ADXS beats the other by $1,593,336,375.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXS + EQR for your $10,000?

ADXS: 50%EQR: 50%

100% EQR50/50100% ADXS

Portfolio after 10yr

$1493.68M

Annual income

$937,262,166.91/yr

Blended yield

62.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ADXS

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-24.8

Piotroski

1/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXS buys

EQR buys

No recent congressional trades found for ADXS or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADXSEQR

Forward yield	331.37% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$2987.30M ✓	$47.8K
Annual income after 10y	$1,874,518,858.21 ✓	$5,475.61
Total dividends collected	$2879.16M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: ADXS vs EQR ($10,000, DRIP)

Year	ADXS Portfolio	ADXS Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$43,837	$33,137.27	$11,380	$679.82	+$32.5K → ADXS
2	$182,667	$135,761.45	$13,014	$837.25	+$169.7K → ADXS
3	$724,155	$528,700.93	$14,961	$1,036.20	+$709.2K → ADXS
4	$2,733,677	$1,958,830.81	$17,297	$1,289.22	+$2.72M → ADXS
5	$9,835,841	$6,910,807.10	$20,121	$1,613.15	+$9.82M → ADXS
6	$33,762,918	$23,238,567.70	$23,561	$2,030.84	+$33.74M → ADXS
7	$110,677,420	$74,551,098.17	$27,783	$2,573.54	+$110.65M → ADXS
8	$346,821,277	$228,396,437.05	$33,013	$3,284.39	+$346.79M → ADXS
9	$1,039,984,991	$668,886,225.19	$39,547	$4,223.51	+$1039.95M → ADXS
10	$2,987,302,799	$1,874,518,858.21	$47,791	$5,475.61	+$2987.26M → ADXS

ADXS vs EQR: Complete Analysis 2026

ADXS — Stock

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Full ADXS Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this ADXS vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXS vs SCHD ADXS vs JEPI ADXS vs O ADXS vs KO ADXS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.